1H), 6.21–6.16 (m, 1H), 4.78–4.66 (m, 2H), 4.13–4.03 (m, 1H),
2.87–2.75 (m, 1H), 1.06 (d, J = 7.3 Hz, 3H). HPLC conditions:
The enantiomeric excess was determined by HPLC (Chiralcel
AS-H), Hex–i-PrOH 90 : 10, UV 210 nm, 0.8 mL min−1, syn: tR
= 24.77 min (major) and tR = 22.84 min (minor).
C14H19NO4 [M − H] 264.1236, Found: 264.1221. IR (v/cm−1):
2964, 2942, 2875, 2840, 2741, 1716, 1601, 1587, 1552, 1494,
1464, 1381, 1246, 1124, 1026, 756.
(6bn)7.
Acknowledgements
(2R,3R)-2-Methyl-4-nitro-3-(thiophen-2-yl)butanal
From aldehyde 4b and nitroolefin 5n at 0 °C according to the
general procedure to give pale yellow oil. H NMR (400 MHz,
This work was partly supported by the National Nature Science
Foundation of China (No. 20972095 and 21172145), Science
and Technology Commission of Shanghai Municipality (No.
10dz1910105), Nippon Chemical Industrial Co., Ltd and Instru-
mental Analysis Center of Shanghai Jiao Tong University. We
thank Prof. Tsuneo Imamoto and Dr Masashi Sugiya of Nippon
Chemical Industrial Co., Ltd for helpful discussion.
1
CDCl3): δ 9.68 (d, J = 1.2 Hz, 1H), 7.25–7.21 (m, 1H),
6.97–6.87 (m, 2H), 4.83–4.64 (m, 2H), 4.27–4.12 (m, 1H),
2.90–2.68 (m, 1H), 1.12 (d, J = 7.3 Hz, 3H). HPLC conditions:
The enantiomeric excess was determined by HPLC (Chiralcel
OZ-H), Hex–i-PrOH 98 : 2, UV 230 nm, 0.95 mL min−1, syn: tR
= 84.95 min (major) and tR = 57.26 min (minor).
(2R,3S)-2-Methyl-4-nitro-3-(pyridin-3-yl)butanal (6bo). From
aldehyde 4b and nitroolefin 5o at 0 °C according to the general
procedure to give pale yellow oil. H NMR (400 MHz, CDCl3):
Notes and references
1
1 For selected reviews on asymmetric Michael additions, see: (a) N. Krause
and A. Hoffmann-Röder, Synthesis, 2001, 171–196; (b) O. M. Berner,
L. Tedeschi and D. Enders, Eur. J. Org. Chem., 2002, 1877–1894;
(c) J. Christoffers and A. Baro, Angew. Chem., Int. Ed., 2003, 42, 1688–
1690; (d) S. B. Tsogoeva, Eur. J. Org. Chem., 2007, 1701–1716;
(e) D. Almaşi, D. A. Alonso and C. Nájera, Tetrahedron: Asymmetry,
2007, 18, 299–365.
δ 9.68 (d, J = 1.4 Hz. 1H), 8.56–8.45 (m, 2H), 7.54–7.50 (m,
1H), 7.33–7.22 (m, 1H), 4.84–4.79 (m, 1H), 4.73–4.65 (m, 1H),
3.90–3.80 (m, 1H), 2.91–2.77 (m, 1H), 1.01 (d, J = 7.4 Hz, 3H).
13C NMR (100 MHz, CDCl3) δ 201.7, 149.9, 149.7, 135.7,
132.8, 124.0, 77.6, 48.1, 41.7, 12.4. HPLC conditions: The
enantiomeric excess was determined by HPLC (Chiralcel
OZ-H), Hex–i-PrOH 75 : 25, UV 210 nm, 0.6 mL min−1, syn: tR
= 49.58 min (major) and tR = 61.62 min (minor). HRMS
(ESI-TOF) Calcd for C10H12N2O3 [M + H] 209.0926, Found:
209.0925. IR (v/cm−1): 3035, 2974, 2935, 2881, 2854, 2730,
1724, 1576, 1556, 1381, 1025, 814, 717.
2 For selected reviews, see: (a) W. Notz, F. Tanaka and C. F. Barbas III,
Acc. Chem. Res., 2004, 37, 580–591; (b) J. L. Vicario, D. Badia and
L. Carrillo, Synthesis, 2007, 2065–2092; (c) S. Sulzer-Mossé and
A. Alexakis, Chem. Commun., 2007, 3123–3135. For selected papers,
see: (d) A. Alexakis and O. Andrey, Org. Lett., 2002, 4, 3611–3614;
(e) O. Andrey, A. Alexakis, A. Tomassini and G. Bernardinelli, Adv.
Synth. Catal., 2004, 346, 1147–1168; (f) T. Ishii, S. Fujioka,
Y. Sekiguchi and H. Kotsuki, J. Am. Chem. Soc., 2004, 126, 9558–9559;
(g) W. Wang, J. Wang and H. Li, Angew. Chem., Int. Ed., 2005, 44,
1369–1371; (h) J. Wang, H. Li, B. Lou, L. Zu, H. Guo and W. Wang,
Chem.–Eur. J., 2006, 12, 4321–4332; (i) M. P. Lalonde, Y. G. Chen and
E. N. Jacobsen, Angew. Chem., Int. Ed., 2006, 45, 6366–6370;
( j) C. Palomo, S. Vera, A. Mielgo and E. Gómez-Bengoa, Angew. Chem.,
Int. Ed., 2006, 45, 5984–5987; (k) Y. Hayashi, T. Itoh, M. Ohkubo and
H. Ishikawa, Angew. Chem., Int. Ed., 2008, 47, 4722–4724;
(l) M. Wiesner, J. D. Revell and H. Wennemers, Angew. Chem., Int. Ed.,
2008, 47, 1871–1874; (m) A. Quintard, C. Bournaud and A. Alexakis,
Chem.–Eur. J., 2008, 14, 7504–7507; (n) M. Lombardo, M. Chiarucci,
A. Quintavalla and C. Trombini, Adv. Synth. Catal., 2009, 351, 2801–
2806; (o) Z. Zheng, B. L. Perkins and B. Ni, J. Am. Chem. Soc., 2010,
132, 50–51; (p) B. G. Wang, B. C. Ma, Q. Wang and W. Wang, Adv.
Synth. Catal., 2010, 352, 2923–2928; (q) Y. Arakawa, M. Wiesner and
H. Wennemers, Adv. Synth. Catal., 2011, 353, 1201–1206; (r) Y.-
M. Chuan, L.-Y. Yin, Y.-M. Zhang and Y.-G. Peng, Eur. J. Org. Chem.,
2011, 578–583; (s) E. M. Omar, K. Dhungana, A. D. Headley and
M. B. A. Rahman, Lett. Org. Chem., 2011, 8, 170–175; (t) T. C. Nugent,
M. Shoaib and A. Shoaib, Org. Biomol. Chem., 2011, 9, 52–56.
3 J. M. Betancort and C. F. Barbas III, Org. Lett., 2001, 3, 3737–3740.
4 D. B. Ramachary, M. S. Prasad and R. Madhavachary, Org. Biomol.
Chem., 2011, 9, 2715–2721.
(2R,3S)-3-(4-Chlorophenyl)-2-isopropyl-4-nitrobutanal (6cb).
From aldehyde 4c and nitroolefin 5b at 0 °C according to the
1
general procedure to give white solid (78.2–80.0 °C). H NMR
(400 MHz, CDCl3): δ 9.90 (d, J = 2.2 Hz, 1H), 7.36–7.27 (m,
2H), 7.16–7.08 (m, 2H), 4.71–4.62 (m, 1H), 4.58–4.47 (m, 1H),
3.92–3.83 (m, 1H), 2.78–2.70 (m, 1H), 1.76–1.64 (m, 1H), 1.10
(d, J = 7.2 Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H). 13C NMR
(100 MHz, CDCl3) δ 204.2, 135.8, 134.2, 129.6, 129.5, 78.9,
58.7, 41.5, 28.1, 21.8, 17.1. HPLC conditions: The enantiomeric
excess was determined by HPLC (Chiralcel OJ-H), Hex–i-PrOH
85 : 15, UV 210 nm, 0.7 mL min−1, syn: tR = 28.95 min (major)
and tR = 26.76 min (minor). HRMS (ESI-TOF) Calcd for
C13H16ClNO3 [M − H] 268.0740, Found: 268.0728. IR (v/
cm−1): 3029, 2964, 2934, 2875, 2845, 2742, 1716, 1554, 1492,
1468, 1379, 1087, 1013, 831, 721.
(2R,3S)-2-Isopropyl-3-(2-methoxyphenyl)-4-nitrobutanal
(6cc). From aldehyde 4c and nitroolefin 5c at 0 °C according to
the general procedure to give pale yellow oil. 1H NMR
(400 MHz, CDCl3): δ 9.91 (d, J = 2.4 Hz, 1H), 7.30–7.23 (m,
1H), 7.11 (dd, J = 7.4, 1.7 Hz, 1H), 6.94–6.83 (m, 2H),
4.83–4.75 (m, 1H), 4.61–4.54 (m, 1H), 4.17–4.07 (m, 1H), 3.85
(s, 3H), 3.08–3.02 (m, 1H), 1.74–1.63 (m, 1H), 1.10 (d, J = 7.2
Hz, 3H), 0.84 (d, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3)
δ 205.1, 157.7, 130.9, 129.4, 124.8, 121.2, 111.4, 77.5, 57.1,
55.5, 39.4, 28.4, 21.9, 17.3. HPLC conditions: The enantiomeric
excess was determined by HPLC (Chiralcel OJ-H), Hex–i-PrOH
96 : 4, UV 210 nm, 0.8 mL min−1, syn: tR = 37.63 min (major)
and tR = 31.79 min (minor). HRMS (ESI-TOF) Calcd for
5 Y. Hayashi, H. Gotoh, T. Hayashi and M. Shoji, Angew. Chem., Int. Ed.,
2005, 44, 4212–4215.
6 L. Q. Gu and G. Zhao, Adv. Synth. Catal., 2007, 349, 1629–1632.
7 R.-S. Luo, J. Weng, H.-B. Ai, G. Lu and A. S. C. Chan, Adv. Synth.
Catal., 2009, 351, 2449–2459.
8 J. Xiao, F. X. Xu, Y. P. Lu and T. P. Loh, Org. Lett., 2010, 12, 1220–
1223.
9 (a) L. Sun, Z. Zhang, F. Xie and W. Zhang, Chin. J. Org. Chem., 2008,
28, 574–587; (b) Y. Ma, Y. J. Zhang, S. Jin, Q. Li, C. Li, J. Lee and
W. Zhang, Tetrahedron Lett., 2009, 50, 7388–7391; (c) S. Jin, C. Li,
Y. Ma, Y. Kan, Y. J. Zhang and W. Zhang, Org. Biomol. Chem., 2010, 8,
4011–4015; (d) Y. Ma, S. Jin, Y. Kan, Y. J. Zhang and W. Zhang, Tetrahe-
dron, 2010, 66, 3849–3854; (e) Z. Zhang, F. Xie, J. Jia and W. Zhang, J.
Am. Chem. Soc., 2010, 132, 15939–15941.
10 W. Zhang, D. Liu and J. Shen, CN patent 2011/0229873.6, 2011.
This journal is © The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 2840–2846 | 2845